Search Results - "Akmalova, Kristina A."

CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis by Sychev, Dmitry A., Parusov, Andrei I., Loranskaya, Irina D., Denisenko, Natalia P., Akmalova, Kristina A., Sozaeva, Zhannet A., Turkina, Olga L., Zastrozhin, Michael S.

“…Aim. To study the polymorphic markers CYP2D6*4 (G1846A, rs3892097), CYP2D6*6 (T1707del, rs5030655), CYP2D6*10 (C100T, rs1065852), CYP2D6*41 (G2988A,…”
Get full text

Effect of polymorphisms in CYP3A422 (rs35599367) C>T, CYP3A53 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results by Sychev, I. N., Fedina, L. V., Osipov, A. S., Temirbulatov, I. I., Tataroy, O. Yu, Sozaeva, Zh. A., Akmalova, K. A., Denisenko, N. P., Abdullaev, S. P., Kachanova, A. A., Grishina, E. A., Mirzaev, K. B., Sychev, D. A.

“…Introduction . Apixaban is a direct oral anticoagulant prescribed for treatment and prevention of venous thromboembolism (VTE) and for prevention of stroke in…”
Get full text

New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants by Mirzaev, K. B., Ivashchenko, D. V., Volodin, I. V., Grishina, E. A., Akmalova, K. A., Kachanova, A. A., Skripka, A. I., Minnigulov, R. M., Morozova, T. E., Baturina, O. A., Levanov, A. N., Shelekhova, T. V., Kalinkin, A. I., Napalkov, D. A., Sokolova, A. A., Andreev, D. A., Sychev, I. N., Bochkov, P. O., Sychev, D. A.

“…Aim . To search for new pharmacogenetic biomarkers of bleeding risk in patients taking rivaroxaban and dabigatran for different indications: atrial…”
Get full text

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring by Rytkin, Eric, Bure, Irina V, Bochkov, Pavel O, Akmalova, Kristina A, Mirzaev, Karin B, Cherniaeva, Marina S, Ostroumova, Olga D, Smirnov, Valery V, Grishina, Elena A, Saribekian, Anna G, Sychev, Igor N, Sychev, Dmitry A

“…The aim of this study is to assess micro-RNAs miR-142 and miR-39 as potential biomarkers for drug-monitoring of rivaroxaban among elderly patients with atrial…”
Get more information

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes by Ivashchenko, Dmitriy V, Yudelevich, Daria A, Buromskaya, Nina I, Shimanov, Pavel V, Deitch, Roman V, Akmalova, Kristina A, Kachanova, Anastasia A, Dorina, Irina V, Nastovich, Marina I, Grishina, Elena A, Savchenko, Lyudmila M, Shevchenko, Yuriy S, Sychev, Dmitriy A

“…To identify possible associations of , and gene polymorphisms with the efficacy and safety of antipsychotics in adolescents with acute psychotic episodes. We…”
Get more information

Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation by Ivashchenko, Dmitriy V, Khoang, Sofi Z, Makhmudova, Bakhu V, Buromskaya, Nina I, Shimanov, Pavel V, Deitch, Roman V, Akmalova, Kristina A, Shuev, Grigoriy N, Dorina, Irina V, Nastovich, Marina I, Shagovenko, Eugenia N, Grishina, Elena A, Savchenko, Lyudmila M, Shevchenko, Yuriy S, Sychev, Dmitriy A

“…Prediction of the antipsychotic's effectiveness is a relevant topic in the field of personalized medicine. The research design of this study is a prospective…”
Get more information